Core Laboratories Inc. (CLB)
- Previous Close
16.69 - Open
16.89 - Bid --
- Ask --
- Day's Range
16.87 - 17.53 - 52 Week Range
13.82 - 27.95 - Volume
420,494 - Avg. Volume
460,908 - Market Cap (intraday)
792.828M - Beta (5Y Monthly) 2.43
- PE Ratio (TTM)
33.31 - EPS (TTM)
0.51 - Earnings Date Jan 30, 2024 - Feb 5, 2024
- Forward Dividend & Yield 0.04 (0.24%)
- Ex-Dividend Date Feb 9, 2024
- 1y Target Est
19.38
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
www.corelab.com3,600
Full Time Employees
December 31
Fiscal Year Ends
Sector
Oil & Gas Equipment & Services
Industry
Recent News: CLB
Performance Overview: CLB
Trailing total returns as of 4/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CLB
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CLB
Valuation Measures
Market Cap
792.83M
Enterprise Value
1.01B
Trailing P/E
33.31
Forward P/E
25.77
PEG Ratio (5yr expected)
2.09
Price/Sales (ttm)
1.59
Price/Book (mrq)
4.06
Enterprise Value/Revenue
2.01
Enterprise Value/EBITDA
15.56
Financial Highlights
Profitability and Income Statement
Profit Margin
7.19%
Return on Assets (ttm)
6.05%
Return on Equity (ttm)
17.68%
Revenue (ttm)
509.79M
Net Income Avi to Common (ttm)
36.67M
Diluted EPS (ttm)
0.51
Balance Sheet and Cash Flow
Total Cash (mrq)
15.12M
Total Debt/Equity (mrq)
93.72%
Levered Free Cash Flow (ttm)
20.82M
Research Analysis: CLB
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Research Reports: CLB
CLB: What does Argus have to say about CLB?
CORE LABORATORIES INC has an Investment Rating of SELL; a target price of $14.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingBearishPrice TargetCLB: What does Argus have to say about CLB?
CORE LABORATORIES INC has an Investment Rating of SELL; a target price of $14.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingBearishPrice TargetCLB: Raising target price to $14.00
CORE LABORATORIES INC has an Investment Rating of SELL; a target price of $14.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingBearishPrice TargetCLB: What does Argus have to say about CLB?
CORE LABORATORIES INC has an Investment Rating of SELL; a target price of $13.000000; an Industry Subrating of Low; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Low; and a Value Subrating of High.
RatingBearishPrice Target